Extracranial oligometastatic renal cell carcinoma: current management and future directions
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracranial oligometastatic renal cell carcinoma: current management and future directions
Authors
Keywords
-
Journal
Future Oncology
Volume 10, Issue 5, Pages 761-774
Publisher
Future Medicine Ltd
Online
2014-05-05
DOI
10.2217/fon.14.40
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatment
- (2016) Mark Warren et al. CUAJ-Canadian Urological Association Journal
- Radiation-Induced IFN- Production within the Tumor Microenvironment Influences Antitumor Immunity
- (2014) A. A. Lugade et al. JOURNAL OF IMMUNOLOGY
- Intrinsic immune alterations in renal cell carcinoma and emerging immunotherapeutic approaches
- (2013) Bruno Bockorny et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
- (2013) Jeannette Oosterwijk-Wakka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety, Efficacy, and Biomarkers of Nivolumab With Vaccine in Ipilimumab-Refractory or -Naive Melanoma
- (2013) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
- (2013) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift
- (2013) Silvia C. Formenti et al. JNCI-Journal of the National Cancer Institute
- Abscopal Effects after Conventional and Stereotactic Lung Irradiation of Non–Small-Cell Lung Cancer
- (2013) Shankar Siva et al. Journal of Thoracic Oncology
- Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- (2013) Charles G. Drake et al. Nature Reviews Clinical Oncology
- Cell mates: paracrine and stromal targets for prostate cancer therapy
- (2013) Pavel Sluka et al. Nature Reviews Urology
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
- (2012) Mark C. Ranck et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma
- (2012) Shankar Siva et al. BJU INTERNATIONAL
- Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma
- (2012) Ehsan H. Balagamwala et al. JOURNAL OF NEUROSURGERY-SPINE
- Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
- (2012) Andrew J. Weickhardt et al. Journal of Thoracic Oncology
- Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
- (2012) Giuseppe V Masucci et al. Journal of Translational Medicine
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases
- (2012) Charles C. L. Tong et al. PLoS One
- Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2--Tumor and Immunological Responses
- (2012) S. K. Seung et al. Science Translational Medicine
- Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases
- (2011) Georgios Meimarakis et al. AMERICAN JOURNAL OF SURGERY
- The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
- (2011) T. Powles et al. ANNALS OF ONCOLOGY
- Survival after complete surgical resection of multiple metastases from renal cell carcinoma
- (2011) Angela L. Alt et al. CANCER
- Stereotactic body radiotherapy for multisite extracranial oligometastases
- (2011) Joseph K. Salama et al. CANCER
- Safety of Presurgical Targeted Therapy in the Setting of Metastatic Renal Cell Carcinoma
- (2011) Brian F. Chapin et al. EUROPEAN UROLOGY
- Tumor Control Outcomes After Hypofractionated and Single-Dose Stereotactic Image-Guided Intensity-Modulated Radiotherapy for Extracranial Metastases From Renal Cell Carcinoma
- (2011) Michael J. Zelefsky et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- MicroRNA Expression Characterizes Oligometastasis(es)
- (2011) Yves A. Lussier et al. PLoS One
- Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy
- (2010) M. Johannsen et al. ANNALS OF ONCOLOGY
- Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
- (2010) Juan Barbastefano et al. BJU INTERNATIONAL
- Oligometastases and Oligo-recurrence: The New Era of Cancer Therapy
- (2010) Y. Niibe et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
- (2010) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Radiotherapy for Pulmonary Oligometastases: A Systematic Review
- (2010) Shankar Siva et al. Journal of Thoracic Oncology
- Metastasectomy After Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
- (2010) Jose A. Karam et al. JOURNAL OF UROLOGY
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
- (2010) Toni K. Choueiri et al. JOURNAL OF UROLOGY
- Functional imaging of renal cell carcinoma
- (2010) Nathan Lawrentschuk et al. Nature Reviews Urology
- Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis
- (2010) Michael D. Staehler et al. WORLD JOURNAL OF UROLOGY
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
- (2009) Y. Lee et al. BLOOD
- Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer
- (2009) S A SOHAIB et al. BRITISH JOURNAL OF RADIOLOGY
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease-free interval and the number of metastases per patient
- (2009) Daniela Wuttig et al. INTERNATIONAL JOURNAL OF CANCER
- Analysis of Patients with Oligometastases Undergoing Two or More Curative-Intent Stereotactic Radiotherapy Courses: In Regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832–837)
- (2009) John P. Christodouleas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Management of Spinal Metastases From Renal Cell Carcinoma Using Stereotactic Body Radiotherapy
- (2009) Quynh-Nhu Nguyen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of surgery in the management of isolated metastases to the pancreas
- (2009) Sushanth Reddy et al. LANCET ONCOLOGY
- Prognostic Factors and Survival of Renal Clear Cell Carcinoma Patients with Bone Metastases
- (2009) Attila Szendrői et al. PATHOLOGY & ONCOLOGY RESEARCH
- Pancreatic Metastasis From Renal Cell Carcinoma: Which Patients Benefit From Surgical Resection?
- (2008) Alessandro Zerbi et al. ANNALS OF SURGICAL ONCOLOGY
- A rationale for the targeted treatment of oligometastases with radiotherapy
- (2008) Dhara M. MacDermed et al. JOURNAL OF SURGICAL ONCOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Thyroid Metastases of Renal Cell Carcinoma: Clinical Course in 45 Patients Undergoing Surgery. Assessment of Factors Affecting Patients' Survival
- (2008) Igors Iesalnieks et al. THYROID
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now